All Three Patients Treated in First Dose Cohort Administered Fludarabine-free Conditioning and Show Rapid, Deep, and ...

Fate Therapeutics (FATE) presented new clinical and translational data from the company’s FT819 Phase 1 Autoimmunity study for ...

On the outskirts of Sednaya prison, known as Syria’s “human slaughterhouse,” a hidden underground complex was uncovered, ...

DAMASCUS - When she heard the stunning news that rebels had brought an end to Syria's decades-old regime, Hayat al-Turki ...

The U.S. has identified prisons of interest as it searches for clues about Austin Tice, who was abducted in 2012 and whose ...

eLife is a non-profit organisation inspired by research funders and led by scientists. Our mission is to help scientists accelerate discovery by operating a platform for research communication that ...

Dec. 5, 2024 — Stem cell transplantation is used to treat several types of blood cancers, but carries the risk of a life-threatening side effect called graft-versus-host disease. Results from a ...

(NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with ...

Veins in the lungs, or pulmonary veins, play a critical role not only in lung functioning but also in maintaining sufficient ...

Thrivent Financial for Lutherans increased its holdings in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 24.7% in the third quarter, according to the company in its most recent ...

Hayat al-Turki has searched the notorious Sednaya prison for four days, finding list of over 7,000 prisoners, wonders if ...